# REpositionable Versus BallOOn-expandable Prosthesis for Trans-catheter Aortic Valve Implantation

Study · id `cardio:ct-nct02668484` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02668484](<https://clinicaltrials.gov/study/NCT02668484>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02668484

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 116 participants.

## Technical summary

Registry record NCT02668484. Randomized; single masking; primary purpose treatment. Start 2016-01 (actual); primary completion 2017-05 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; single masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 116 participants (enrolled count; ClinicalTrials.gov record NCT02668484, source copy `cardio:ctgov-nct02668484-2019-06-03`, retrieved 2026-10-26)
- Started: 2016-01 (actual) (ClinicalTrials.gov record NCT02668484, source copy `cardio:ctgov-nct02668484-2019-06-03`, retrieved 2026-10-26)
- Primary completion: 2017-05 (actual) (ClinicalTrials.gov record NCT02668484, source copy `cardio:ctgov-nct02668484-2019-06-03`, retrieved 2026-10-26)
- Completion: 2019-05-31 (actual) (ClinicalTrials.gov record NCT02668484, source copy `cardio:ctgov-nct02668484-2019-06-03`, retrieved 2026-10-26)
- Countries: Germany; Italy (ClinicalTrials.gov record NCT02668484, source copy `cardio:ctgov-nct02668484-2019-06-03`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02668484-2019-06-03`, retrieved 2026-10-26)

## The registry's words

- Brief title: REpositionable Versus BallOOn-expandable Prosthesis for Trans-catheter Aortic Valve Implantation
- Acronym: REBOOT
- Condition: Aortic Valve Disease
- Intervention (Device): repositionable valve prosthesis
- Intervention (Device): balloon-expandable valve prosthesis
- Lead sponsor: LMU Klinikum
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: LMU Klinikum (`cardio:org-lmu-klinikum`)

## Provenance

Content hash: 5f275282a2835842a80a4592382e6969d2ffef79c2490bacfaddb648d324d308
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
